Skip to content

Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders

Using Precision Performance Measurement To Conduct Focused Quality Improvement. Sub-Study 1.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00793455
Acronym
UPQUAL
Enrollment
628
Registered
2008-11-19
Start date
2008-10-31
Completion date
2009-11-30
Last updated
2011-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer Screening, Prevention & Control

Keywords

education, preventive service, screening

Brief summary

The purpose of this study is to evaluate whether patient outreach is effective at increasing compliance with preventive screenings ordered by their physician. We hypothesize that educational outreach may increase completion rates.

Detailed description

We designed an intervention to focus on patients who have received and accepted a referral for colonoscopy, yet have exhibited some barriers to screening as demonstrated by a lack of screening completion. We conducted a randomized controlled trial to assess the effects of a multicomponent intervention (patient reminder, print and multimedia materials) on colorectal screening completion among this target population.

Interventions

Participants will get a letter from their physician that explains that their records show the test has not been completed. The letter will be mailed along with an educational brochure and a DVD about colorectal cancer and colorectal cancer screening.

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient's physician has ordered a preventive screening test * Patient has not completed this test in 3 months * Patient of Northwestern Medical Faculty Foundation General Internal Medicine Clinic.

Exclusion criteria

* Patient has been given a more recent order for the same screening test. * Patient has significant life stress as noted in the Electronic Health Record (EHR)

Design outcomes

Primary

MeasureTime frameDescription
Colorectal Cancer Screening Completion.3 months post randomizationWe reviewed electronic health records of participants 3 months post randomization to ascertain outcome. We looked for one or both of the following (1) note in free text MD note documenting receipt of one form of colorectal cancer (CRC) screening during study period (2)lab results from fecal occult blood test, sigmoidoscopy, or colonoscopy. Participants were categorized as completing CRC screening if there was a lab result or physician note located in chart during study period. If no note or lab result was found in chart, then the participant was categorized as not completing CRC screening.

Secondary

MeasureTime frameDescription
Colorectal Cancer Screening Completion6 months post randomizationWe reviewed electronic health records of participants 6 months post randomization to ascertain outcome. We looked for one or both of the following (1) note in free text MD note documenting receipt of one form of colorectal cancer (CRC) screening during study period (2)lab results from fecal occult blood test, sigmoidoscopy, or colonoscopy. Participants were categorized as completing CRC screening if there was a lab result or physician note located in chart during study period. If no note or lab result was found in chart, then the participant was categorized as not completing CRC screening.

Countries

United States

Participant flow

Recruitment details

This trial took place at a large urban academic primary care internal medicine practice in Chicago, IL. This trial was enrolling patients between October 2008 and May 2009.

Pre-assignment details

We used data contained in the clinic's electronic health record to identify eligible patients. All eligible patients were randomly assigned in equal numbers to either the control or intervention arms. All eligible patients were randomized and assigned to groups until we reached target study size.

Participants by arm

ArmCount
Intervention Group
Participants assigned to this group received a one-time educational intervention within one week of randomization. Educational intervention consisted of a letter from patient's physician, a brochure about colorectal cancer screening, and a DVD about colorectal cancer screening.
314
Usual Care Control Group
Participants in this arm will receive normal care until outcome assessment is performed at 6 months following the placement of the order for the preventive service. They will be sent a letter reminding them to obtain the ordered preventive service test.
314
Total628

Baseline characteristics

CharacteristicIntervention GroupUsual Care Control GroupTotal
Age Continuous57.90 years
STANDARD_DEVIATION 7.1
58.03 years
STANDARD_DEVIATION 6.6
58.0 years
STANDARD_DEVIATION 6.9
Colorectal Cancer (CRC) screening history
Ever screened
22 Participants24 Participants46 Participants
Colorectal Cancer (CRC) screening history
Never screened
292 Participants290 Participants582 Participants
Insurance Status
Medicaid
10 Participants10 Participants20 Participants
Insurance Status
Medicare
56 Participants63 Participants119 Participants
Insurance Status
Private
245 Participants236 Participants481 Participants
Insurance Status
Uninsured
3 Participants5 Participants8 Participants
Number of visits in past 2 years
1-2
69 Participants79 Participants148 Participants
Number of visits in past 2 years
3
80 Participants79 Participants159 Participants
Number of visits in past 2 years
4
54 Participants48 Participants102 Participants
Number of visits in past 2 years
>=5
111 Participants108 Participants219 Participants
Race/Ethnicity, Customized
Black
79 participants77 participants156 participants
Race/Ethnicity, Customized
Hispanic
9 participants14 participants23 participants
Race/Ethnicity, Customized
Other/unknown
82 participants91 participants173 participants
Race/Ethnicity, Customized
White
144 participants132 participants276 participants
Region of Enrollment
United States
314 participants314 participants628 participants
Sex: Female, Male
Female
197 Participants192 Participants389 Participants
Sex: Female, Male
Male
117 Participants122 Participants239 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Colorectal Cancer Screening Completion.

We reviewed electronic health records of participants 3 months post randomization to ascertain outcome. We looked for one or both of the following (1) note in free text MD note documenting receipt of one form of colorectal cancer (CRC) screening during study period (2)lab results from fecal occult blood test, sigmoidoscopy, or colonoscopy. Participants were categorized as completing CRC screening if there was a lab result or physician note located in chart during study period. If no note or lab result was found in chart, then the participant was categorized as not completing CRC screening.

Time frame: 3 months post randomization

Population: Analysis was based on intention to treat.

ArmMeasureGroupValue (NUMBER)
Usual Care Control GroupColorectal Cancer Screening Completion.Did not Complete Screening304 participants
Usual Care Control GroupColorectal Cancer Screening Completion.Completed Screening10 participants
Intervention GroupColorectal Cancer Screening Completion.Did not Complete Screening283 participants
Intervention GroupColorectal Cancer Screening Completion.Completed Screening31 participants
Comparison: We compared the outcomes in the intervention and control groups using rate ratios and chi square test at 3 and 6 months, a 2 sided test with a p value \< .05 was used to determine significance. The study was powered to detect a 10-percentage point difference in screening completion between intervention and control groups if the control rate of completion as 20% or less with 80% power.p-value: <0.0595% CI: [1.5, 6.2]Chi-squared
Secondary

Colorectal Cancer Screening Completion

We reviewed electronic health records of participants 6 months post randomization to ascertain outcome. We looked for one or both of the following (1) note in free text MD note documenting receipt of one form of colorectal cancer (CRC) screening during study period (2)lab results from fecal occult blood test, sigmoidoscopy, or colonoscopy. Participants were categorized as completing CRC screening if there was a lab result or physician note located in chart during study period. If no note or lab result was found in chart, then the participant was categorized as not completing CRC screening.

Time frame: 6 months post randomization

Population: Analysis was based on intention to treat.

ArmMeasureGroupValue (NUMBER)
Usual Care Control GroupColorectal Cancer Screening CompletionCompleted Screening38 participants
Usual Care Control GroupColorectal Cancer Screening CompletionDid not Complete Screening276 participants
Intervention GroupColorectal Cancer Screening CompletionDid not Complete Screening257 participants
Intervention GroupColorectal Cancer Screening CompletionCompleted Screening57 participants
Comparison: Same as primary outcome.p-value: <0.0595% CI: [1.03, 2.2]Chi-squared

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026